Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
6
×
deals
6
×
europe blog main
6
×
europe top stories
life sciences
national blog main
national top stories
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
alzheimer's disease
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
merck
pfizer
philadelphia blog main
philadelphia top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amag pharmaceuticals
What
bio
roundup
amid
bombast
buy
cancer
caught
coronavirus
days
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
week
acquisitions
alliance
approval
arrival
betting
biggest
billion
biopharma
biotech
bristol
build
calls
ceo
changing
color
companies
Language
unset
Current search:
deals
×
" europe blog main "
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
